"Welcome to SSJ Finance"

Profit & Loss Accounts

Quarterly Results

Cohance Lifesciences Ltd
Industry : Pharmaceuticals - Indian - Bulk Drugs & Formln	Chairman : Vivek Sharma
Home : Indian Private	Book Value: 60.8611266
BSE Code : 543064	Market Cap: 37021.02
NSE Code : COHANCE	P / E : 104.84

Change Company :

Quarters:

(Rs in Cr.)

Quarterly Results

Particulars	Jun 2025	Mar 2025	Dec 2024	Sep 2024
Type	1Qtr	4Qtr	3Qtr	2Qtr
Net Sales	483.58	768.57	284.27	236.06
Other Income	13.10	8.19	15.50	13.43
Total Income	496.68	776.76	299.77	249.49
Total Expenditure	387.48	561.58	171.05	135.05
Operating Profit	109.20	215.18	128.72	114.44
Interest	6.80	7.00	2.62	1.47
Gross Profit	102.40	208.18	126.10	112.97
Depreciation	31.36	42.58	14.88	12.29
Tax	18.15	30.74	41.79	27.91
Deferred Tax	0.32	12.09	-14.24	-3.56
Reported Profit After Tax	52.57	122.77	83.67	76.33

SSJ FINANCE & SECURITIES PRIVATE LIMITED:
1st Floor, Merchant Chamber, Opp. Patkar Hall, 41, New Marine Lines, Mumbai – 400 020
SEBI Regn. Number: INZ000178436 | CDSL: IN-DP-109-2015 | ARN: 40860 | CIN: U67120MH1996PTC104822

SSJ COMMODITIES PRIVATE LIMITED:
SEBI Regn. Number: INZ000013439 | CIN: U51909MH2003PTC140481|Research Analyst SEBI Reg. No.INH000001527

Content powered by Capital Market Charts are powered by TradingView